Supportive Care in Cancer

, Volume 21, Issue 8, pp 2207–2215 | Cite as

Transient swelling versus lymphoedema in the first year following surgery for breast cancer

  • Sharon L. Kilbreath
  • Mi-Joung Lee
  • Kathryn M. Refshauge
  • Jane M. Beith
  • Leigh C. Ward
  • J. M. Simpson
  • D. Black
Original Article

Abstract

Purpose

The aim was to better understand the incidence, time course and risk factors for swelling in the arm on the side of surgery over the first year following surgery for breast cancer.

Method

Women (n = 160) were assessed 1 month following surgery and then randomised to the exercise or control group. Reassessment occurred 3, 9 and 15 months following surgery. Potential risk factors for swelling included age, body mass index, side of surgery and surgical and medical treatments for their breast cancer, physical measures of shoulder range of motion and strength, inter-limb arm circumference difference and the group to which they were randomised. Swelling was determined using bioimpedance spectroscopy with reference to previously established cut-offs for lymphoedema.

Results

The number of women with swelling at 3, 9 and 15 months was 15, 15 and 13, respectively; however, at 15 months only 5/13 presented with swelling in either of the preceding assessments. The risk of swelling increased at 3, 9 and 15 months for each centimetre increase in the baseline inter-limb difference in sum of arm circumferences by 1.30, 1.17 and 1.14. In addition, risk of swelling at 3 months was 2.6 times greater for women in the control group; at 9 months, 7 times greater for women who had taxane-based chemotherapy; and at 15 months, the risk increased 1.16 times for each day the drain was in situ.

Conclusion

Swelling in the first year is likely to be transient, and factors including exercise and taxane chemotherapy affect the risk of developing swelling.

Keywords

Extracellular fluid Risk factor Predictor Lymphoedema 

Notes

Acknowledgments

The Cancer Council NSW provided a grant to support this project. SLK is supported by the National Breast Cancer Foundation, Australia.

Conflict of interest

Author Ward has consulted to ImpediMed Ltd. ImpediMed Ltd. had no involvement in the conception and execution of this study or in the preparation of the manuscript.

References

  1. 1.
    Rockson SG: Update on the biology and treatment of lymphedema. Curr Treat Options Cardiovasc Med 2012.Google Scholar
  2. 2.
    Stanton AW, Modi S, Mellor RH, Levick JR, Mortimer PS (2009) Recent advances in breast cancer-related lymphedema of the arm: lymphatic pump failure and predisposing factors. Lymphat Res Biol 7(1):29–45PubMedCrossRefGoogle Scholar
  3. 3.
    Norman SA, Localio AR, Potashnik SL, Simoes Torpey HA, Kallan MJ, Weber AL, Miller LT, Demichele A, Solin LJ (2009) Lymphedema in breast cancer survivors: incidence, degree, time course, treatment, and symptoms. J Clin Oncol 27(3):390–397PubMedCrossRefGoogle Scholar
  4. 4.
    Hayes SC, Janda M, Cornish B, Battistutta D, Newman B (2008) Lymphedema after breast cancer: incidence, risk factors, and effect on upper body function. J Clin Oncol 26(21):3536–3542PubMedCrossRefGoogle Scholar
  5. 5.
    Lane KN, Dolan LB, Worsley D, McKenzie DC, Lane KN, Dolan LB, Worsley D, McKenzie DC (2007) Upper extremity lymphatic function at rest and during exercise in breast cancer survivors with and without lymphedema compared with healthy controls. J Appl Physiol 103(3):917–925PubMedCrossRefGoogle Scholar
  6. 6.
    Zawieja D (2005) Lymphatic biology and the microcirculation: past, present and future. Microcirculation 12(1):141–150PubMedCrossRefGoogle Scholar
  7. 7.
    Coates G, O’Brodovich H, Goeree G (1993) Hindlimb and lung lymph flows during prolonged exercise. J Appl Physiol 75(2):633–638PubMedGoogle Scholar
  8. 8.
    McGeown JG, McHale NG, Thornbury KD (1987) The role of external compression and movement in lymph propulsion in the sheep hind limb. J Physiol 387:83–93PubMedGoogle Scholar
  9. 9.
    Hormes JM, Bryan C, Lytle LA, Gross CR, Ahmed RL, Troxel AB, Schmitz KH (2010) Impact of lymphedema and arm symptoms on quality of life in breast cancer survivors. Lymphology 43(1):1–13PubMedGoogle Scholar
  10. 10.
    Helyer LK, Varnic M, Le LW, Leong W, McCready D: Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients. Breast J 2009:1–7.Google Scholar
  11. 11.
    Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, Miller LT, Fox KR, DeMichele A, Solin LJ (2010) Risk factors for lymphedema after breast cancer treatment. Cancer Epidemiol Biomarkers Prev 19(11):2734–2746PubMedCrossRefGoogle Scholar
  12. 12.
    Swenson KK, Nissen MJ, Leach JW, Post-White J (2009) Case–control study to evaluate predictors of lymphedema after breast cancer surgery. Oncol Nurs Forum 36(2):185–193PubMedCrossRefGoogle Scholar
  13. 13.
    Yen TW, Fan X, Sparapani R, Laud PW, Walker AP, Nattinger AB (2009) A contemporary, population-based study of lymphedema risk factors in older women with breast cancer. Ann Surg Oncol 16(4):979–988PubMedCrossRefGoogle Scholar
  14. 14.
    Bronstad A, Berg A, Reed RK (2004) Effects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressure. Am J Physiol Heart Circ Physiol 287(2):H963–968PubMedCrossRefGoogle Scholar
  15. 15.
    Qin YY, Li H, Guo XJ, Ye XF, Wei X, Zhou YH, Zhang XJ, Wang C, Qian W, Lu J et al (2011) Adjuvant chemotherapy, with or without taxanes, in early or operable breast cancer: a meta-analysis of 19 randomized trials with 30698 patients. PLoS One 6(11):e26946PubMedCrossRefGoogle Scholar
  16. 16.
    Stout Gergich NL, Pfalzer LA, McGarvey C, Springer B, Gerber LH, Soballe P (2008) Preoperative assessment enables the early diagnosis and successful treatment of lymphedema. Cancer 112(12):2809–2819PubMedCrossRefGoogle Scholar
  17. 17.
    Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Lee M, Simpson JM, Hansen R: Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trial. Breast Cancer Res Treat 2012.Google Scholar
  18. 18.
    Kilbreath SL, Refshauge KM, Beith JM, Ward LC, Simpson JM, Hansen RD (2006) Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial. BMC Cancer 6:273PubMedCrossRefGoogle Scholar
  19. 19.
    Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRefGoogle Scholar
  20. 20.
    Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 13(5):1249–1254PubMedGoogle Scholar
  21. 21.
    Cornish BH, Jacobs A, Thomas BJ, Ward LC (1999) Optimizing electrode sites for segmental bioimpedance measurements. Physiol Meas 20(3):241–250PubMedCrossRefGoogle Scholar
  22. 22.
    Ward LC, Kilbreath S, Cornish BH: Bioimpedance analysis for early detection of lymphedema. In: Lymphedema: Diagnosis and therapy. Edited by Weissieder H, Schuchhardt C, 4th edn. Essen: Viavital 2008: 502–517.Google Scholar
  23. 23.
    Karges JR, Mark BE, Stikeleather SJ, Worrell TW (2003) Concurrent validity of upper-extremity volume estimates: comparison of calculated volume derived from girth measurements and water displacement volume. Phys Ther 83(2):134–145PubMedGoogle Scholar
  24. 24.
    Ward LC, Dylke E, Czerniec S, Isenring E, Kilbreath SL (2011) Confirmation of the reference impedance ratios used for assessment of breast cancer-related lymphedema by bioelectrical impedance spectroscopy. Lymphat Res Biol 9(1):47–51PubMedCrossRefGoogle Scholar
  25. 25.
    McNutt L-A, Wu C, Xue X, Hafner J (2003) Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157(10):940–943PubMedCrossRefGoogle Scholar
  26. 26.
    Armer JM, Stewart BR (2010) Post-breast cancer lymphedema: incidence increases from 12 to 30 to 60 months. Lymphology 43(3):118–127PubMedGoogle Scholar
  27. 27.
    Courneya KS, Segal RJ, Mackey JR, Gelmon K, Reid RD, Friedenreich CM, Ladha AB, Proulx C, Vallance JK, Lane K et al (2007) Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial. J Clin Oncol 25(28):4396–4404PubMedCrossRefGoogle Scholar
  28. 28.
    Schmitz KH, Ahmed RL, Troxel AB, Cheville A, Lewis-Grant L, Smith R, Bryan CJ, Williams-Smith CT, Chittams J (2010) Weight lifting for women at risk for breast cancer-related lymphedema: a randomized trial. JAMA 304(24):2699–2705PubMedCrossRefGoogle Scholar
  29. 29.
    Cavanaugh KM (2011) Effects of early exercise on the development of lymphedema in patients with breast cancer treated with axillary lymph node dissection. J Oncol Pract 7(2):89–93PubMedCrossRefGoogle Scholar
  30. 30.
    Cheema B, Gaul CA, Lane K, Singh MAF (2008) Progressive resistance training in breast cancer: a systematic review of clinical trials. Breast Cancer Res Treat 109(1):9–26PubMedCrossRefGoogle Scholar
  31. 31.
    Borg GA (1982) Psychophysical bases of perceived exertion. Med Sci Sports Exerc 14(5):377–381PubMedGoogle Scholar
  32. 32.
    Matthews K, Smith J (1996) Effectiveness of modified complex physical therapy for lymphoedema treatment. Aust J Physiother 42(4):323–328PubMedGoogle Scholar
  33. 33.
    Ridner SH (2002) Breast cancer lymphedema: pathophysiology and risk reduction guidelines. Oncol Nurs Forum 29(9):1285–1293PubMedCrossRefGoogle Scholar
  34. 34.
    Lee TS, Kilbreath SL, Sullivan G, Refshauge KM, Beith JM, Harris LM (2009) Factors that affect intention to avoid strenuous arm activity after breast cancer surgery. Oncol Nurs Forum 36(4):454–462PubMedCrossRefGoogle Scholar
  35. 35.
    Schoeller D: Hydrometry. In: Human body composition. Edited by Roche A, Heymsfield S, Lohman T. Champaign, IL: Human Kinetics; 1996: 25–43.Google Scholar
  36. 36.
    Stanton AW, Mellor RH, Cook GJ, Svensson WE, Peters AM, Levick JR, Mortimer PS (2003) Impairment of lymph drainage in subfascial compartment of forearm in breast cancer-related lymphedema. Lymphat Res Biol 1(2):121–132PubMedCrossRefGoogle Scholar
  37. 37.
    Stanton AW, Modi S, Bennett Britton TM, Purushotham AD, Peters AM, Levick JR, Mortimer PS (2009) Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment. Breast Cancer Res Treat 117(3):549–557PubMedCrossRefGoogle Scholar
  38. 38.
    Cornish BH, Chapman M, Thomas BJ, Ward LC, Bunce IH, Hirst C (2000) Early diagnosis of lymphedema in postsurgery breast cancer patients. Ann N Y Acad Sci 904:571–575PubMedCrossRefGoogle Scholar
  39. 39.
    Czerniec SA, Ward LC, Refshauge KM, Beith J, Lee MJ, York S, Kilbreath SL (2010) Assessment of breast cancer-related arm lymphedema—comparison of physical measurement methods and self-report. Cancer Invest 28(1):54–62PubMedCrossRefGoogle Scholar
  40. 40.
    Lee TS, Kilbreath SL, Refshauge KM, Pendlebury SC, Beith JM, Lee MJ (2007) Pectoral stretching program for women undergoing radiotherapy for breast cancer. Breast Cancer Res Treat 102(3):313–321PubMedCrossRefGoogle Scholar
  41. 41.
    Alfano CM, Day JM, Katz ML, Herndon JE 2nd, Bittoni MA, Oliveri JM, Donohue K, Paskett ED (2009) Exercise and dietary change after diagnosis and cancer-related symptoms in long-term survivors of breast cancer: CALGB 79804. Psychooncology 18(2):128–133PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Sharon L. Kilbreath
    • 1
  • Mi-Joung Lee
    • 1
  • Kathryn M. Refshauge
    • 1
  • Jane M. Beith
    • 2
  • Leigh C. Ward
    • 1
    • 3
  • J. M. Simpson
    • 4
  • D. Black
    • 1
  1. 1.Faculty of Health SciencesUniversity of SydneyLidcombe, SydneyAustralia
  2. 2.Royal Prince Alfred HospitalSydney Cancer CentreCamperdownAustralia
  3. 3.School of Chemistry and Molecular BiosciencesThe University of QueenslandBrisbaneAustralia
  4. 4.School of Public HealthUniversity of SydneySydneyAustralia

Personalised recommendations